195 related articles for article (PubMed ID: 33342047)
1. Octreotide versus oral dietary modification for the treatment of chylous fistula following neck dissection: A systematic review and meta-analysis.
Molena E; King E; Davies-Husband C
Clin Otolaryngol; 2021 May; 46(3):474-484. PubMed ID: 33342047
[TBL] [Abstract][Full Text] [Related]
2. Conservative management of postoperative chylous fistula with octreotide and peripheral total parenteral nutrition.
Chan JY; Wong EW; Ng SK; van Hasselt CA; Vlantis AC
Ear Nose Throat J; 2017 Jul; 96(7):264-267. PubMed ID: 28719710
[TBL] [Abstract][Full Text] [Related]
3. Use of Octreotide for the Management of Chyle Fistula Following Neck Dissection.
Swanson MS; Hudson RL; Bhandari N; Sinha UK; Maceri DR; Kokot N
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):723-7. PubMed ID: 26135979
[TBL] [Abstract][Full Text] [Related]
4. A prospective study on the role of octreotide in management of chyle fistula neck.
Jain A; Singh SN; Singhal P; Sharma MP; Grover M
Laryngoscope; 2015 Jul; 125(7):1624-7. PubMed ID: 25639346
[TBL] [Abstract][Full Text] [Related]
5. Chyle Fistula After Neck Dissection: An 8-Year, Single-Center, Prospective Study of Incidence, Clinical Features, and Treatment.
Ahn D; Sohn JH; Jeong JY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1000-6. PubMed ID: 26286200
[TBL] [Abstract][Full Text] [Related]
6. Negative Pressure Wound Therapy (Wound VAC) in the Treatment of Chylous Fistula After Neck Dissection.
Dorneden A; Olson G; Boyd N
Ann Otol Rhinol Laryngol; 2019 Jun; 128(6):569-574. PubMed ID: 30693805
[TBL] [Abstract][Full Text] [Related]
7. [Cervical chylous fistula after lymphadenectomy for papillary thyroid carcinoma treated with somatostatin analogs].
Cascales Campos PA; Ríos Zambudio A; Rodríguez González JM; Parrilla Paricio P
Endocrinol Nutr; 2011 Mar; 58(3):150-1. PubMed ID: 21353652
[No Abstract] [Full Text] [Related]
8. "How I do it"--head and neck. A targeted problem and its solution. Chylous fistula prevention and management.
Thawley SE
Laryngoscope; 1980 Mar; 90(3):522-5. PubMed ID: 7359974
[TBL] [Abstract][Full Text] [Related]
9. [Chyle fistula. Medical management with octreotide].
Bejarano Glez-Serna D; Utrera-Glez A; Cordoncillo-Prieto JM; de la Portilla de Juan F; Rada-Morgades R; Carranza-Albarran G
Cir Esp; 2006 Apr; 79(4):250-1. PubMed ID: 16753107
[TBL] [Abstract][Full Text] [Related]
10. Effect of Octreotide in stopping post surgical chyle leak in neck Dissection-A systematic review.
Magoo S; Bhate K; Santhosh Kumar SN; Kakodkar P; Gajul M; Mastud S
J Oral Biol Craniofac Res; 2022; 12(5):737-741. PubMed ID: 36110865
[TBL] [Abstract][Full Text] [Related]
11. Evolution of chylous fistula management after neck dissection.
Campisi CC; Boccardo F; Piazza C; Campisi C
Curr Opin Otolaryngol Head Neck Surg; 2013 Apr; 21(2):150-6. PubMed ID: 23449286
[TBL] [Abstract][Full Text] [Related]
12. The use of atropine in treatment of chylous fistula complicated by thyroid carcinoma surgery.
Lin N; Zhou C; Yan L; Wang Y
Asian J Surg; 2020 Jan; 43(1):369-371. PubMed ID: 31635934
[No Abstract] [Full Text] [Related]
13. Management of chylous fistula as a complication of neck dissection: a 10-year retrospective review.
Santaolalla F; Anta JA; Zabala A; Del Rey Sanchez A; Martinez A; Sanchez JM
Eur J Cancer Care (Engl); 2010 Jul; 19(4):510-5. PubMed ID: 20030699
[TBL] [Abstract][Full Text] [Related]
14. Chyle fistula as complication of thyroid surgery in malignant pathology.
Ríos A; Rodríguez JM; Torregrosa NM; Hernández AM; Parrilla P
Endocrinol Diabetes Nutr (Engl Ed); 2019 Apr; 66(4):247-253. PubMed ID: 30309811
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of octreotide in the treatment of chyle fistulas associated with pancreatic disease].
Zárate Moreno FA; Oms Bernad LM; Mato Ruiz R; Balaguer del Ojo C; Sala Pedrós J; Campillo Alonso F
Cir Esp; 2013 Apr; 91(4):237-42. PubMed ID: 23228417
[TBL] [Abstract][Full Text] [Related]
16. Chylous Fistula following Axillary Lymphadenectomy: Benefit of Octreotide Treatment.
González-Sánchez-Migallón E; Aguilar-Jiménez J; García-Marín JA; Aguayo-Albasini JL
Case Rep Surg; 2016; 2016():6098019. PubMed ID: 26925285
[TBL] [Abstract][Full Text] [Related]
17. Chylous fistula after axillary lymph node dissection: incidence, management, and possible cause.
Singh M; Deo SV; Shukla NK; Pandit A
Clin Breast Cancer; 2011 Oct; 11(5):320-4. PubMed ID: 21729668
[TBL] [Abstract][Full Text] [Related]
18. Role of Octreotide in Conservative Management of Chyle Leak Post Neck Dissection in Cases of Head Neck Cancer: A Retrospective Analysis.
Gupta V; Dwivedi G; Chugh R; Sahu PK; Gupta DK; Basu A; Upadhyay K; Patnaik U; Bhatia R
Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):6078-6086. PubMed ID: 36742480
[TBL] [Abstract][Full Text] [Related]
19. Octreotide for conservative management of intractable high output post operative chylous fistula: a case report.
Prabhu S; Thomas S
J Maxillofac Oral Surg; 2015 Mar; 14(Suppl 1):21-4. PubMed ID: 25838666
[TBL] [Abstract][Full Text] [Related]
20. Prolonged iatrogenic thoracic duct chylous fistula in neck surgery: conservative management or surgery? A literature review.
Parmeggiani D; Gualtieri G; Terracciano G; Gambardella C; Parisi S; Brusciano L; Ruggiero R; Docimo L
Scand J Surg; 2021 Dec; 110(4):550-556. PubMed ID: 33423617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
